The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Over 6 million adults in the U.S. have heart failure (HF), with increasing incidence.
• High prevalence of HF risk factors (hypertension, diabetes, obesity) affects a large U.S. population, with disproportionate impact on certain racial and ethnic groups.
• The rising health and economic burden of HF necessitates a focus on prevention strategies.

Purpose of the Study:

• To highlight the role of primary and secondary prevention in HF, as detailed in the 2022 AHA/ACC/HFSA Heart Failure Guideline.
• To discuss the contribution of the preventive cardiology community in mitigating HF prevalence.
• To underscore the importance of addressing HF risk factors in at-risk populations.

Main Methods:

• Review of the 2022 American Heart Association / American College of Cardiology / Heart Failure Society of America (AHA/ACC/HFSA) Heart Failure Guideline.
• Analysis of current HF prevalence and risk factor data in the U.S.
• Discussion of preventive cardiology's role in HF management.

Main Results:

• The 2022 AHA/ACC/HFSA guideline strongly emphasizes HF prevention.
• Multiple risk factors, including hypertension, diabetes, and obesity, significantly increase HF risk.
• Preventive cardiology plays a crucial role in reducing HF incidence.

Conclusions:

• Primary and secondary prevention strategies are essential for managing the growing burden of heart failure.
• The preventive cardiology community is vital in implementing guideline-recommended strategies to reduce HF prevalence.
• Addressing multifactorial risk in diverse populations is key to HF prevention.